Key result
LASP1 mRNA was upregulated 2.66-fold in esophageal squamous cell carcinoma tissues compared to adjacent normal tissues, and its silencing in vitro significantly inhibited cell proliferation, migration, and invasion.
Why the study?
Does silencing of LASP1 reduce proliferation, migration, and invasion in esophageal squamous cell carcinoma cells?
Does silencing of LASP1 reduce proliferation, migration, and invasion in esophageal squamous cell carcinoma cells?
Effect estimate: 2.66-fold upregulation
p-value: p=0.018
LASP1 is overexpressed in esophageal squamous cell carcinoma and its silencing inhibits tumor cell proliferation, migration, and invasion in vitro, suggesting it may be a potential therapeutic target.
LASP1 inhibition merits further preclinical validation in esophageal squamous cell carcinoma; in vitro data leave open clinical translation.
LIM and SH3 protein 1 (LASP1) is an actin-binding protein which is overexpressed in many types of cancers and plays important roles in cancer progression. however, the role of LASP1 in esophageal squamous cell carcinoma (ESCC) is still unknown. We sought to analyze the expression level of LASP1 in ESCC, and the role of LASP1 in the development of ESCC was further investigated. We evaluated the expression levels of LASP1 in 89 ESCC tissues and two ESCC cell lines using quantitative real-time polymerase chain reaction, western blotting and immunohistochemistry. The effects of LASP1 depletion on tumor cell behavior were investigated using gene transfection and small interfering RNA (siRNA) in ESCC cell lines in vitro. The expression levels of LASP1 at the mRNA and protein levels were significantly higher in ESCC tissues and ESCC cell lines compared to adjacent tissues. Immunohistochemistry showed that LASP1 was localized in the cytoplasm and nuclei of tumor epithelia. Silencing of LASP1 in ECA109 and KYSE510 cell lines significantly inhibited cell proliferation, migration and invasion when compared with the negative control cells in vitro. LASP1 may play an important role in the pathogenesis of ESCC and shows promise as a treatment target in ESCC.
No takes yet. Share an insight, caveat, or question.
He et al. (2012) studied Esophageal squamous cell carcinoma (n=89). LASP1 expression vs. Adjacent normal esophageal tissues was evaluated on LASP1 mRNA expression levels (2.66-fold upregulation, p=0.018). LASP1 mRNA was upregulated 2.66-fold in esophageal squamous cell carcinoma tissues compared to adjacent normal tissues, and its silencing in vitro significantly inhibited cell proliferation, migration, and invasion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: